DM
BIO icon

Deerfield Management’s Bio-Rad Laboratories Class A BIO Stock Holding History

Deerfield Management’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$66.4M Hold
226,070
– – 0.69% 39
2026
Q1 		$63M Hold
226,070
– – 0.74% 40
2025
Q4 		$68.5M Hold
226,070
– – 0.87% 31
2025
Q3 		$63.4M Hold
226,070
– – 0.97% 29
2025
Q2 		$54.6M Hold
226,070
– – 0.99% 26
2025
Q1 		$55.1M Buy
226,070
+74,426
+49% +$22.4M 1.09% 24
2024
Q4 		$49.8M Buy
151,644
+69
+0% +$23.4K 0.94% 29
2024
Q3 		$50.7M Sell
151,575
-139
-0.1% -$44.1K 0.76% 28
2024
Q2 		$41.4M Sell
151,714
-664
-0.4% -$193K 0.69% 36
2024
Q1 		$52.7M Buy
152,378
+803
+0.5% +$264K 0.92% 27
2023
Q4 		$48.9M Sell
151,575
-22,372
-13% -$7.01M 0.9% 31
2023
Q3 		$62.4M Buy
+173,947
New +$67.1M 1.37% 19

Other funds holding BIO

First Eagle Investment Management
First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Deerfield Management's BIO Position: Q2 2026 in Review

Deerfield Management held its Bio-Rad Laboratories Class A (BIO) position steady in Q2 2026 at 226,070 shares worth $66.4M. The position accounts for 0.69% of the portfolio, ranked #39.

Deerfield Management first reported a position in BIO in Q3 2023 and has held it in 12 quarters since. The position peaked at $68.5M in Q4 2025. 397 funds tracked by Wall St. Rank hold BIO as of Q2 2026.

  • Deerfield Management held 226,070 shares of Bio-Rad Laboratories Class A worth $66.4M as of Q2 2026.
  • Deerfield Management left its Bio-Rad Laboratories Class A share count unchanged in Q2 2026.
  • Bio-Rad Laboratories Class A made up 0.69% of Deerfield Management's portfolio in Q2 2026, its #39 holding.
  • Deerfield Management first reported a position in Bio-Rad Laboratories Class A in Q3 2023 and has held it in 12 quarters since.
  • Deerfield Management's Bio-Rad Laboratories Class A position peaked at $68.5M in Q4 2025.
  • 397 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q2 2026.

Based on Deerfield Management's 13F filing for Q2 2026, filed 14 Aug 2026.